🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to learn if patients being treated with second...
Status
Completed
Location
Center for Health Care Services
Start Date
2009-01
Trial ID
NCT01115114
Exercise-induced laryngeal obstruction (EILO) is a condition in which the l...
Status
Completed
Location
Liverpool University Hospitals Nhs Foundation Trust
Start Date
2022-03-24
Trial ID
NCT05314478
Treatments Being Tested
Breast cancer is the most common malignant disease among women worldwide, w...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-10-01
Trial ID
NCT07205276
Gut-derived endotoxaemia, microbial imbalance and bacterial translocation p...
Status
Withdrawn
Location
Hospital Beaujon, Hepatology and Liver Intensive Care,
Start Date
2021-01-31
Trial ID
NCT03962608
The purpose of this study is to determine whether the availability of home ...
Status
Completed
Location
Public Health - Seattle & King County STD Clinic, located at Harborview Medical Center
Start Date
2010-07
Trial ID
NCT01161446
This study will utilize approved devices in an off-label manner to create f...
Status
Terminated
Location
Michigan Medicine
Start Date
2023-03-06
Trial ID
NCT06185088
Treatments Being Tested
The eRADAR Brain Health Study seeks to refine and test a novel, low-cost st...
Status
Completed
Location
Kaiser Permanente Burien Medical Center
Start Date
2022-06-29
Trial ID
NCT05356702
Treatments Being Tested
Alzheimer disease (AD) is a neurodegenerative disorder with a poorly unders...
Status
Completed
Location
Multiple Locations
Start Date
2016-06
Trial ID
NCT03548883
The purpose of this research is to improve the ability of primary medical s...
Status
Completed
Location
Henan Provincical Peoples Hospital
Start Date
2018-04-14
Trial ID
NCT03452241
Treatments Being Tested
Tocilizumab concentrations above 1 mg/L are likely to be sufficient for nor...
Status
Unknown
Location
Reade Rheumatology Research Institute
Start Date
2020-03-01
Trial ID
NCT03895879
Treatments Being Tested